Reviva Pharmaceuticals (RVPHW) Stock Chart & Stock Price History $0.06 -0.01 (-13.60%) As of 11:23 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisChartCompetitorsHeadlinesSEC FilingsShort InterestTrendsBuy This Stock Reviva Pharmaceuticals Stock Price Performance The Reviva Pharmaceuticals (RVPHW) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 80.93%, with a year-to-date return of -65.21%. In the past month, the stock has decreased 9.92%, reflecting recent market activity. As of the latest close, Reviva Pharmaceuticals traded at $0.07 with a market cap of and volume of 128,782 shares. Receive RVPHW Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Reviva Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance+16.02%1 Month Performance-9.92%3 Month Performance-52.77%Year-To-Date Performance-65.21%1 Year Performance-80.93% RVPHW Stock Chart for Friday, May, 23, 2025 RVPHW Chart by TradingView Reviva Pharmaceuticals Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/22/2025$0.06$0.07+10.33%$0.07$0.05128,782 shs$0.0005/21/2025$0.05$0.06+18.81%$0.08$0.05120,128 shs$0.0005/20/2025$0.06$0.05-13.68%$0.06$0.0532,380 shs$0.0005/19/2025$0.05$0.06+18.66%$0.06$0.0468,380 shs$0.0005/16/2025$0.05$0.05-6.45%$0.05$0.0430,330 shs$0.0005/15/2025$0.05$0.05-1.31%$0.06$0.0426,616 shs$0.0005/14/2025$0.05$0.05+6.80%$0.06$0.03115,569 shs$0.0005/13/2025$0.06$0.05-10.39%$0.06$0.0570,538 shs$0.0005/12/2025$0.05$0.06+11.60%$0.06$0.0432,441 shs$0.0005/09/2025$0.06$0.05-20.51%$0.06$0.0510,166 shs$0.00 Get the Latest News and Ratings for RVPHW and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Reviva Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 05/08/2025$0.06$0.06+12.93%$0.06$0.0520,526 shs$0.0005/07/2025$0.05$0.06+1.64%$0.06$0.0433,779 shs$0.0005/06/2025$0.05$0.05+8.09%$0.06$0.0439,421 shs$0.0005/05/2025$0.06$0.05-21.40%$0.05$0.0555,391 shs$0.0005/02/2025$0.06$0.06+11.98%$0.06$0.0512,642 shs$0.0005/01/2025$0.06$0.06-5.57%$0.07$0.05108,852 shs$0.0004/30/2025$0.07$0.06-8.68%$0.07$0.0545,853 shs$0.0004/29/2025$0.07$0.07+2.77%$0.07$0.0518,398 shs$0.0004/28/2025$0.06$0.07+4.50%$0.07$0.0553,066 shs$0.0004/25/2025$0.07$0.06-11.14%$0.06$0.0626,277 shs$0.0004/24/2025$0.06$0.07+10.24%$0.07$0.0626,894 shs$0.0004/23/2025$0.06$0.06+10.63%$0.09$0.0633,546 shs$0.0004/22/2025$0.05$0.06+7.29%$0.07$0.0647,820 shs$0.00 Related Companies 180 Life Sciences Stock Price Chart 4D pharma Stock Price Chart Aesther Healthcare Acquisition Stock Price Chart Ainos Stock Price Chart Alvotech Stock Price Chart Atlantic Coastal Acquisition Corp. II Stock Price Chart Biofrontera Stock Price Chart biote Stock Price Chart BriaCell Therapeutics Stock Price Chart Celularity Stock Price Chart Receive RVPHW Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Reviva Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:RVPHW) was last updated on 5/23/2025 by MarketBeat.com Staff From Our PartnersWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredA grave, grave error.I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredGold Alert: The Truth About Fort Knox Is ComingOwning physical gold isn’t the best way to profit. I’ve found a better way to invest in gold—one that’s alr...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Reviva Pharmaceuticals Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Reviva Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.